company background image
MDRX logo

Veradigm OTCPK:MDRX Stock Report

Last Price

US$9.40

Market Cap

US$1.6b

7D

-3.7%

1Y

-10.5%

Updated

23 Dec, 2024

Data

Company Financials +

MDRX Stock Overview

A healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. More details

MDRX fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance0/6
Financial Health0/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Veradigm Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Veradigm
Historical stock prices
Current Share PriceUS$9.40
52 Week HighUS$11.80
52 Week LowUS$5.01
Beta0
1 Month Change-13.28%
3 Month Change-4.18%
1 Year Change-10.48%
3 Year Change-48.89%
5 Year Change-4.47%
Change since IPO72.79%

Recent News & Updates

Recent updates

Veradigm (NASDAQ:MDRX) Is Doing The Right Things To Multiply Its Share Price

Feb 28
Veradigm (NASDAQ:MDRX) Is Doing The Right Things To Multiply Its Share Price

Veradigm (NASDAQ:MDRX) Might Have The Makings Of A Multi-Bagger

Nov 10
Veradigm (NASDAQ:MDRX) Might Have The Makings Of A Multi-Bagger

Veradigm's (NASDAQ:MDRX) Returns On Capital Are Heading Higher

Mar 06
Veradigm's (NASDAQ:MDRX) Returns On Capital Are Heading Higher

Is It Too Late To Consider Buying Veradigm Inc. (NASDAQ:MDRX)?

Feb 13
Is It Too Late To Consider Buying Veradigm Inc. (NASDAQ:MDRX)?

Veradigm Inc. (NASDAQ:MDRX) Shares Could Be 47% Below Their Intrinsic Value Estimate

Jan 22
Veradigm Inc. (NASDAQ:MDRX) Shares Could Be 47% Below Their Intrinsic Value Estimate

These 4 Measures Indicate That Veradigm (NASDAQ:MDRX) Is Using Debt Reasonably Well

Jan 04
These 4 Measures Indicate That Veradigm (NASDAQ:MDRX) Is Using Debt Reasonably Well

Returns Are Gaining Momentum At Allscripts Healthcare Solutions (NASDAQ:MDRX)

Dec 03
Returns Are Gaining Momentum At Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare reaffirms 2022 financial guidance; shares fall 2%

Sep 28

Should You Think About Buying Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Now?

Sep 17
Should You Think About Buying Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Now?

Investors Will Want Allscripts Healthcare Solutions' (NASDAQ:MDRX) Growth In ROCE To Persist

Aug 24
Investors Will Want Allscripts Healthcare Solutions' (NASDAQ:MDRX) Growth In ROCE To Persist

We Think Allscripts Healthcare Solutions (NASDAQ:MDRX) Is Taking Some Risk With Its Debt

Jul 31
We Think Allscripts Healthcare Solutions (NASDAQ:MDRX) Is Taking Some Risk With Its Debt

Is Now An Opportune Moment To Examine Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)?

Jun 15
Is Now An Opportune Moment To Examine Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)?

Shareholder Returns

MDRXUS Healthcare ServicesUS Market
7D-3.7%0.6%-2.2%
1Y-10.5%2.2%23.9%

Return vs Industry: MDRX underperformed the US Healthcare Services industry which returned 2.2% over the past year.

Return vs Market: MDRX underperformed the US Market which returned 23.4% over the past year.

Price Volatility

Is MDRX's price volatile compared to industry and market?
MDRX volatility
MDRX Average Weekly Movement6.7%
Healthcare Services Industry Average Movement9.4%
Market Average Movement6.3%
10% most volatile stocks in US Market17.0%
10% least volatile stocks in US Market3.1%

Stable Share Price: MDRX has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: MDRX's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1986n/aTom Langanveradigm.com

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as Veradigm Connect, Veradigm App Expo, and Diagnostic Ordering and Resulting Network; Channel Partner Program; and Veradigm ePrescribe Enterprise.

Veradigm Inc. Fundamentals Summary

How do Veradigm's earnings and revenue compare to its market cap?
MDRX fundamental statistics
Market capUS$1.61b
Earnings (TTM)US$115.91m
Revenue (TTM)US$1.53b

0.0x

P/E Ratio

0.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MDRX income statement (TTM)
RevenueUS$1.53b
Cost of RevenueUS$754.78m
Gross ProfitUS$774.22m
Other ExpensesUS$658.31m
EarningsUS$115.91m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did MDRX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 00:29
End of Day Share Price 2024/12/23 00:00
Earnings2022/09/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Veradigm Inc. is covered by 46 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Gregory BolanAvondale Partners
Matthew GillmorBaird